X0508 4 2024-09-12 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001373603 Leonard Braden Michael 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 true false Common Stock 2024-09-12 4 P 0 36176 1.3966 A 2980196 I Holding of BML Investment Partners, L.P. Common Stock 2024-09-13 4 P 0 150000 1.313 A 3130196 I Holding of BML Investment Partners, L.P. Common Stock 2024-09-16 4 P 0 172747 1.3712 A 3302943 I Holding of BML Investment Partners, L.P. Common Stock 1020769 D BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Purchased in multiple transactions with a weighted average price of $1.3966. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Purchased in multiple transactions with a weighted average price of $1.313. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Purchased in multiple transactions with a weighted average price of $1.3712. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Braden Michael Leonard 2024-09-16